AUTHOREA
Log in Sign Up Browse Preprints

December 20, 2022
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardl...
Ian Pavord, Arnaud Bourdin, Alberto Papi, et al.